- The shares of Oak Street Health (OSH) recently received a $29 price target from Goldman Sachs. These are the details.
The shares of Oak Street Health (OSH) recently received a $29 price target from Goldman Sachs.
Price target: $29
Rating: Neutral
Analyst: Goldman Sachs analyst Jamie Perse
Perse adjusted the rating while citing more cautious outlook reflecting the company’s growth-profitability constraints. And Oak Street’s current level of growth – 30-40 centers per year in 2023 and beyond – will require more cash than is currently available, and the lack of visibility on this will be an overhang. But Perse noted that despite a downgrade, the company’s longer term unit economic story is still compelling and that significant value creation opportunity may still be ahead after near-term challenges are addressed.
Source: pulse2.com
